Antibodies against phospholipids other than cardiolipin: Potential roles for both phospholipid and protein

Lupus

Volumn 5, Issue 5, 1996, Pages 498-502

  Rauch, J ^a   Janoff, A S ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b Liposome Company Incorporated   (United States)

Author keywords

Anti phospholipid antibodies; Lupus anticoagulants; Phospholipid binding proteins; Phospholipids

Indexed keywords

KININOGEN; LIPOCORTIN 5; LUPUS ANTICOAGULANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; PRIORITY JOURNAL;

EID: 0029830387     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500534     Document Type: Conference Paper

References (62)

1. Harris EN et al. Crossreactivity of anti-phospholipid antibodies. J Clin Lab Immunol 1985; 16: 1-6.
2. Weidmann CE et al. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 1988; 15: 74-79.
3. Triplett DA, Brandt JT, Musgrave KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid JAMA, J Am Med Assoc 1988; 259: 550-554.
4. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193-280.
5. Galli M et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547.
6. 2-Glycoprotein I (apolipoprotern H). Proc Natl Acad Sci USA 1990; 87: 4120-4124.
7. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Haemost 1992; 68: 297-300.
8. 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int J Biochem 1984; 16: 511-515.
9. Rauch J et al. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 1986; 261: 9672-9677.
10. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989; 62: 892-896.
11. Rauch J, Tannenbaum M, Taraschi T, Janoff AS. Direct binding of lupus anticoagulant antibodies to nonbilayer phospholipids (submitted for publication).
12. Karmochkine M et al. Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis. Clin Exp Rheumatol 1992; 10: 603-605.
13. Branch DW, Rote NS, Dostal DA, Scott JR. Association of lupus anticoagulant with antibody against phosphatidylserine. Clin Immunol Immunopathol 1987; 42: 63-75.
14. Staub HL et al. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis 1989; 48: 166-169.
15. Falcon CR, Hoffer AM, Carreras LO. Evaluation of the clinical and laboratory associations of antiphosphatidylethanolamine antibodies. Thromb Res 1990; 59: 383-388.
16. Karmochkine M et al. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 1993; 2: 157-160.
17. 2 glycoprotein-I plasma levels. Autoimmunity 1993; 16: 245-249.
18. Sugi T, McIntyre JA. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex. Blood 1995; 86: 3083-3089.
19. Bevers EM et al. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-632.
20. Oosting JD et al. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: An explanation for their pathogenic mechanism?. Blood 1993; 81: 2618-2625.
21. Loeliger A. Prothrombin as co-factor of the circulating anticoagulant in systemic lupus erythematosus?. Thromb Diath Haemorrh 1959; 3: 237-256.
22. Arvieux J et al. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-1125.
23. Edson JR, Vogt JM, Hasegawa DK. Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood 1984; 64: 807-816.
24. Fleck RA, Rapaport SI, Rao LVM. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-519.
25. Wu JR, Lentz BR. Phospholipid-specific conformational changes in human prothrombin upon binding to procoagulant acidic lipid membranes. Thromb Haemost 1994; 71: 596-604.
26. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other 'antiphospholipid' antibodies. Blood 1994; 84: 2854-2867.
27. Sammaritano LR et al. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J Clin Immunol 1992; 12: 27-35.
28. Matsuda J et al. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody. Am J Hematol 1994; 47: 56-58.
29. Matsuda J et al. Anti-annexin antibody in the sera of patients with habitual fetal loss or preeclampsia. Thromb Res 1994; 75: 105-106.
30. Nakamura N et al. Heterogeneity and diversity of IgM and IgG lupus anticoagulants in an individual with systemic lupus erythematosus. Biochem Biophys Res Commun 1994; 203: 1789-1794.
31. Nakamura N et al. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: Involvement of annexin V. Biochem Biophys Res Commun 1994; 205: 1488-1493.
32. Tait JF, Gibson D. Phospholipid binding of annexin V: Effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 1992; 298: 187-191.
33. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265:17420-17423.
34. Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991; 266: 24302-24307.
35. Dachary-Prigent J et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-2565.
36. Ruiz-Argüelles A et al. Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C deficiencies. Am J Hematol 1993; 44: 58-59.
37. Parke AL et al. The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S. Am J Med 1992; 93: 49-56.
38. Op den Kamp JAF. Lipid asymmetry in membranes. Ann Rev Biochem 1979; 48: 47-71.
39. Comfurius P, Bevers EM, Galli M, Zwaal RFA. Regulation of phospholipid asymmetry and induction of antiphospholipid antibodies. Lupus 1995; 4 (Suppl. 1): S19-S22.
40. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736: 57-66.
41. Rote NS et al. Immunologic detection of phosphatidylserine extemalization during thrombin-induced platelet activation. Clin Immunol Immunopathol 1993; 66: 193-200.
42. 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: Differences with lupus anticoagulants. Blood 1993; 81: 1255-1262.
43. 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmunity 1994; 7: 335-348.
44. Schwartz RS et al. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 1985; 75: 1965-1972.
45. Schroit AJ, Madsen JW, Tanaka Y. In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 1985; 260: 5131-5138.
46. Fadok VA et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992; 148: 2207-2216.
47. Fadok VA et al. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol 1993; 151: 4274-4285.
48. 2-glycoprotein I-dependent manner. J Immunol 1996; 157: 2201-2208.
49. Harris EN et al. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-2156.
50. Hazeltine M et al. Antiphospholipid antibodies in systemic lupus erythematosus: Evidence of an association with positive Coombs' and hypocomplementemia. J Rheumatol 1988; 15: 80-86.
51. Cabral AR, Cabiedes J, Alarcón-Segovia D. Hemolytic anemia related to an IgM autoantibody to phosphatidylcholine that binds in vitro to stored and to bromelain-treated human erythrocytes. J Autoimmunity 1990; 3: 773-787.
52. Arvieux J, Schweizer B, Roussel B, Colomb MG. Autoimmune haeraolytic anaemia due to anti-phospholipid antibodies. Vox Sang 1991; 61: 190-195.
53. Arvieux J, Roussel B, Ponard D, Colomb MG. Reactivity patterns of anti-phospholipid antibodies in systemic lupus erythematosus sera in relation to erythrocyte binding and complement activation. Clin Exp Immunol 1991; 84: 466-471.
54. Fortin PR, Andrejchyshyn S, Senécal J-L, Rauch J. Anti-phospholipid reactivity of Coombs' positive antibodies in SLE. Lupus 1994; 3 (4): 350 (Abstract).
55. Mollison PL, (ed). Blood Transfusion in Clinical Medicine. 7th Ed. Oxford, UK, Blackwell Scientific Publications, 1983, pp 330-401; 440-480.
56. o(D) antibody. Mol Immunol 1984; 21: 433-438.
57. Green FA. Erythrocyte membrane lipids and Rh antigen activity. J Biol Chem 1972; 247: 881-887.
58. Connor J, Bucana C, Fidler IJ, Schroit AJ. Differentiation-dependent expression of phosphatidyl-serine in mammalian plasma membranes: quantitative assessment of outer leaflet lipid by prothrombinase complex formation. Proc Natl Acad Sci USA 1989; 86: 3184-3188.
59. 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. J Immunol 1995; 154: 954-960
60. Rauch J, Janoff A. The nature of anti-phospholipid antibodies. J Rheumatol 1992; 19: 1782-1785.
61. Ranch J et al. A unique antigenic epitope is exposed on apolipoprotein H when it interacts with native cardiolipin (submitted for publication).
62. 2-GP1). Clin Exp Immunol 1995; 102: 373-378.